Although at least 35,000 human genes have been sequenced and mapped, adequate expression or functional information is available for only approximately 15% of them. Gene-trap mutagenesis is a technique that randomly generates loss-of-function mutations and reports the expression of many mouse genes. At present, several large-scale, gene-trap screens are being carried out with various new vectors, which aim to generate a public resource of mutagenized embryonic stem (ES) cells. This resource now includes more than 8,000 mutagenized ES-cell lines, which are freely available, making it an appropriate time to evaluate the recent advances in this area of genomic technology and the technical hurdles it has yet to overcome.
Loss-of-function mutations in the murine dominant white spotting ͞c-kit locus affect a diverse array of biological processes and cell lineages and cause a range of phenotypes, including severe anemia, defective pigmentation, sterility, mast cell deficits, a lack of interstitial cells of Cajal, spatial learning memory deficits, and defects in peripheral nerve regeneration. Here we show that tyrosine residues 567 and 569 in the juxtamembrane (Jx) domain of the murine Kit receptor tyrosine kinase are crucial for the function of Kit in melanogenesis and mast cell development, but are dispensable for the normal development of erythroid, interstitial cells of Cajal and germ cells. Furthermore, adult mice lacking both tyrosines exhibit splenomegaly, dysregulation of B-cell and megakaryocyte development, and enlarged stomachs. Analysis of signal transduction events induced by the mutant receptors after ligand stimulation indicates that Jx tyrosine mutations diminish receptor autophosphorylation and selectively attenuate activation of extracellular signal-regulated kinase͞mitogen-activated protein kinases. Together, these observations demonstrate that the Jx domain of Kit plays a cell-type specific regulatory role in vivo and illustrate how engineered mutations in Kit can be used to understand the complex biological and molecular events that result from activating a receptor tyrosine kinase.T he Kit receptor tyrosine kinase (RTK) is centrally involved in the development of multiple cell lineages, including hematopoietic and germ cells, melanocytes, and the interstitial cells of Cajal (ICC) (1-4). Insights into the roles of this receptor and its cognate ligand, stem cell factor (SCF), in these developmental processes have been greatly facilitated by the large series of naturally occurring mutations in the murine genes that encode these molecules, the dominant white spotting (W) and steel (Sl) loci, respectively. Thus, mice with loss-of-functions in either the W or Sl loci are anemic and exhibit white spotting, sterility, and a concomitant loss of the ICC and intestinal pacemaker activity.Ligand binding to the Kit RTK induces receptor dimerization and autophosphorylation of specific tyrosine residues (5, 6). These phosphorylation events create docking sites for specific Src homology 2 (SH2) domain-containing proteins, which in turn control various intracellular signaling pathways (7). Recruitment of particular targets is mediated by the ability of their SH2 domains to recognize specific phosphotyrosine (pTyr)-containing motifs on the activated receptor (8). Numerous signaling molecules have been identified as binding partners for specific pTyr residues on activated Kit, including the p85 subunit of phosphatidylinositol 3Ј kinase (by means of tyrosine 719), phospholipase C␥ (by means of tyrosine 728), and the Grb2 and Grb7 adapter proteins (by means of tyrosine residues 702 and 934) (6). Additionally, signaling molecules, including Src family kinases and the protein tyrosine phosphatases Shp-1 and Shp-2, have been shown to ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.